Gene Therapy for CNS Disorders Market 2022: Key Strategies, Historical Analysis, Trends, New Opportunities and Forecast Till 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report elaborates the market size, market characteristics, and market growth of the Gene Therapy for CNS Disorders industry, and breaks down according to the type, application, and consumption area of Gene Therapy for CNS Disorders. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Gene Therapy for CNS Disorders in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Gene Therapy for CNS Disorders market covered in Chapter 13:
Biogen
bluebird bio, Inc.
Novartis AG
Pfizer Inc.
Roche (Spark Therapeutics)
Voyager Therapeutics
In Chapter 6, on the basis of types, the Gene Therapy for CNS Disorders market from 2015 to 2025 is primarily split into:
AAV
Adenovirus
In Chapter 7, on the basis of applications, the Gene Therapy for CNS Disorders market from 2015 to 2025 covers:
SMA
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Gene Therapy for CNS Disorders Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Gene Therapy for CNS Disorders Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Gene Therapy for CNS Disorders Market Forces
3.1 Global Gene Therapy for CNS Disorders Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Gene Therapy for CNS Disorders Market - By Geography
4.1 Global Gene Therapy for CNS Disorders Market Value and Market Share by Regions
4.1.1 Global Gene Therapy for CNS Disorders Value ($) by Region (2015-2020)
4.1.2 Global Gene Therapy for CNS Disorders Value Market Share by Regions (2015-2020)
4.2 Global Gene Therapy for CNS Disorders Market Production and Market Share by Major Countries
4.2.1 Global Gene Therapy for CNS Disorders Production by Major Countries (2015-2020)
4.2.2 Global Gene Therapy for CNS Disorders Production Market Share by Major Countries (2015-2020)
4.3 Global Gene Therapy for CNS Disorders Market Consumption and Market Share by Regions
4.3.1 Global Gene Therapy for CNS Disorders Consumption by Regions (2015-2020)
4.3.2 Global Gene Therapy for CNS Disorders Consumption Market Share by Regions (2015-2020)
5 Gene Therapy for CNS Disorders Market - By Trade Statistics
5.1 Global Gene Therapy for CNS Disorders Export and Import
5.2 United States Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.3 Europe Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.4 China Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.5 Japan Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.6 India Gene Therapy for CNS Disorders Export and Import (2015-2020)
5.7
6 Gene Therapy for CNS Disorders Market - By Type
6.1 Global Gene Therapy for CNS Disorders Production and Market Share by Types (2015-2020)
6.1.1 Global Gene Therapy for CNS Disorders Production by Types (2015-2020)
6.1.2 Global Gene Therapy for CNS Disorders Production Market Share by Types (2015-2020)
6.2 Global Gene Therapy for CNS Disorders Value and Market Share by Types (2015-2020)
6.2.1 Global Gene Therapy for CNS Disorders Value by Types (2015-2020)
6.2.2 Global Gene Therapy for CNS Disorders Value Market Share by Types (2015-2020)
6.3 Global Gene Therapy for CNS Disorders Production, Price and Growth Rate of AAV (2015-2020)
6.4 Global Gene Therapy for CNS Disorders Production, Price and Growth Rate of Adenovirus (2015-2020)
7 Gene Therapy for CNS Disorders Market - By Application
7.1 Global Gene Therapy for CNS Disorders Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Gene Therapy for CNS Disorders Consumption by Applications (2015-2020)
7.1.2 Global Gene Therapy for CNS Disorders Consumption Market Share by Applications (2015-2020)
7.2 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of SMA (2015-2020)
7.3 Global Gene Therapy for CNS Disorders Consumption and Growth Rate of Others (2015-2020)
8 North America Gene Therapy for CNS Disorders Market
8.1 North America Gene Therapy for CNS Disorders Market Size
8.2 United States Gene Therapy for CNS Disorders Market Size
8.3 Canada Gene Therapy for CNS Disorders Market Size
8.4 Mexico Gene Therapy for CNS Disorders Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Gene Therapy for CNS Disorders Market Analysis
9.1 Europe Gene Therapy for CNS Disorders Market Size
9.2 Germany Gene Therapy for CNS Disorders Market Size
9.3 United Kingdom Gene Therapy for CNS Disorders Market Size
9.4 France Gene Therapy for CNS Disorders Market Size
9.5 Italy Gene Therapy for CNS Disorders Market Size
9.6 Spain Gene Therapy for CNS Disorders Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Gene Therapy for CNS Disorders Market Analysis
10.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size
10.2 China Gene Therapy for CNS Disorders Market Size
10.3 Japan Gene Therapy for CNS Disorders Market Size
10.4 South Korea Gene Therapy for CNS Disorders Market Size
10.5 Southeast Asia Gene Therapy for CNS Disorders Market Size
10.6 India Gene Therapy for CNS Disorders Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Gene Therapy for CNS Disorders Market Analysis
11.1 Middle East and Africa Gene Therapy for CNS Disorders Market Size
11.2 Saudi Arabia Gene Therapy for CNS Disorders Market Size
11.3 UAE Gene Therapy for CNS Disorders Market Size
11.4 South Africa Gene Therapy for CNS Disorders Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Gene Therapy for CNS Disorders Market Analysis
12.1 South America Gene Therapy for CNS Disorders Market Size
12.2 Brazil Gene Therapy for CNS Disorders Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Biogen
13.1.1 Biogen Basic Information
13.1.2 Biogen Product Profiles, Application and Specification
13.1.3 Biogen Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.2 bluebird bio, Inc.
13.2.1 bluebird bio, Inc. Basic Information
13.2.2 bluebird bio, Inc. Product Profiles, Application and Specification
13.2.3 bluebird bio, Inc. Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.3 Novartis AG
13.3.1 Novartis AG Basic Information
13.3.2 Novartis AG Product Profiles, Application and Specification
13.3.3 Novartis AG Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.4 Pfizer Inc.
13.4.1 Pfizer Inc. Basic Information
13.4.2 Pfizer Inc. Product Profiles, Application and Specification
13.4.3 Pfizer Inc. Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.5 Roche (Spark Therapeutics)
13.5.1 Roche (Spark Therapeutics) Basic Information
13.5.2 Roche (Spark Therapeutics) Product Profiles, Application and Specification
13.5.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Market Performance (2015-2020)
13.6 Voyager Therapeutics
13.6.1 Voyager Therapeutics Basic Information
13.6.2 Voyager Therapeutics Product Profiles, Application and Specification
13.6.3 Voyager Therapeutics Gene Therapy for CNS Disorders Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.2 Europe Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.3 Asia-Pacific Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.4 Middle East and Africa Gene Therapy for CNS Disorders Market Forecast (2020-2025)
14.5 South America Gene Therapy for CNS Disorders Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Gene Therapy for CNS Disorders Market Forecast by Types (2020-2025)
15.1.1 Global Gene Therapy for CNS Disorders Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Gene Therapy for CNS Disorders Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Gene Therapy for CNS Disorders Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Gene Therapy for CNS Disorders Picture
Table Gene Therapy for CNS Disorders Key Market Segments
Figure Study and Forecasting Years
Figure Global Gene Therapy for CNS Disorders Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Gene Therapy for CNS Disorders Value ($) and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Value ($) by Countries (2015-2020)
Table Global Gene Therapy for CNS Disorders Value Market Share by Regions (2015-2020)
Figure Global Gene Therapy for CNS Disorders Value Market Share by Regions in 2019
Figure Global Gene Therapy for CNS Disorders Production and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Production by Major Countries (2015-2020)
Table Global Gene Therapy for CNS Disorders Production Market Share by Major Countries (2015-2020)
Figure Global Gene Therapy for CNS Disorders Production Market Share by Regions in 2019
Figure Global Gene Therapy for CNS Disorders Consumption and Growth Rate (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption by Regions (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Regions (2015-2020)
Figure Global Gene Therapy for CNS Disorders Consumption Market Share by Regions in 2019
Table Global Gene Therapy for CNS Disorders Export Top 3 Country 2019
Table Global Gene Therapy for CNS Disorders Import Top 3 Country 2019
Table United States Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Europe Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table China Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Japan Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table India Gene Therapy for CNS Disorders Export and Import (2015-2020)
Table Global Gene Therapy for CNS Disorders Production by Types (2015-2020)
Table Global Gene Therapy for CNS Disorders Production Market Share by Types (2015-2020)
Figure Global Gene Therapy for CNS Disorders Production Share by Type (2015-2020)
Table Global Gene Therapy for CNS Disorders Value by Types (2015-2020)
Table Global Gene Therapy for CNS Disorders Value Market Share by Types (2015-2020)
Figure Global Gene Therapy for CNS Disorders Value Share by Type (2015-2020)
Figure Global AAV Production and Growth Rate (2015-2020)
Figure Global AAV Price (2015-2020)
Figure Global Adenovirus Production and Growth Rate (2015-2020)
Figure Global Adenovirus Price (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption by Applications (2015-2020)
Table Global Gene Therapy for CNS Disorders Consumption Market Share by Applications (2015-2020)
Figure Global Gene Therapy for CNS Disorders Consumption Share by Application (2015-2020)
Figure Global SMA Consumption and Growth Rate (2015-2020)
Figure Global Others Consumption and Growth Rate (2015-2020)
Figure North America Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table North America Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table North America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure North America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure United States Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Canada Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Mexico Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Europe Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Europe Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Europe Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Germany Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure France Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Italy Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Spain Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Asia-Pacific Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure China Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Japan Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South Korea Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure India Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table Middle East and Africa Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure UAE Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South Africa Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Figure South America Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table South America Gene Therapy for CNS Disorders Consumption by Countries (2015-2020)
Table South America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure South America Gene Therapy for CNS Disorders Consumption Market Share by Countries (2015-2020)
Figure Brazil Gene Therapy for CNS Disorders Market Consumption and Growth Rate (2015-2020)
Table Biogen Company Profile
Table Biogen Production, Value, Price, Gross Margin 2015-2020
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table bluebird bio, Inc. Company Profile
Table bluebird bio, Inc. Production, Value, Price, Gross Margin 2015-2020
Figure bluebird bio, Inc. Production and Growth Rate
Figure bluebird bio, Inc. Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Roche (Spark Therapeutics) Company Profile
Table Roche (Spark Therapeutics) Production, Value, Price, Gross Margin 2015-2020
Figure Roche (Spark Therapeutics) Production and Growth Rate
Figure Roche (Spark Therapeutics) Value ($) Market Share 2015-2020
Table Voyager Therapeutics Company Profile
Table Voyager Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Voyager Therapeutics Production and Growth Rate
Figure Voyager Therapeutics Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Production by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Production Share by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Value ($) by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Value Share by Types (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Consumption by Applications (2020-2025)
Table Global Gene Therapy for CNS Disorders Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Gene Therapy for CNS Disorders Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|